Voclosporin In Stock CAS NO.515814-01-4

Voclosporin Basic information
Product Name:    Voclosporin
Synonyms:    Isatx 247;Isatx247;Isatx-247;Luveniq;Lx211;R 1524;Voclosporin;Voclosporin [usan]
CAS:    515814-01-4
MF:    C63H111N11O12
MW:    1214.65
EINECS:    
Product Categories:    Intermediates & Fine Chemicals;Peptides;Pharmaceuticals;API
Mol File:    515814-01-4.mol

Voclosporin Chemical Properties
Boiling point     1303.8±65.0 °C(Predicted)
density     1.016±0.06 g/cm3(Predicted)
storage temp.     Store at -20°C
solubility     Benzene (Slightly), Methanol (Slightly)
pka    13.32±0.70(Predicted)
form     Solid
color     White to Off-White

Voclosporin Usage And Synthesis
Description    Voclosporin, a structurally similar analogue of cyclosporin A, is a new type of calcineurin inhibitor. It has been modified to increase its activity by 3-4 times and exhibits a dual and synergistic mechanism. This drug works by blocking the expression of IL-2 and T cell-mediated immune response, stabilizing renal podocytes. Compared to cyclosporin, voclosporin has the advantage of having less impact on cholesterol and triglycerides and a lower risk of diabetes. In February 2021, vorcyclosporine was approved by the FDA for use in combination immunosuppressive regimens in adult patients with active, lupus nephritis.
Uses    A new agent for the treatment of noninfectious uveitis. Uveitis is an inflammatory, putative Th1-mediated autoimmune disease that affects various parts of the eye and is a leading cause of visual loss. Voclosporin, a rationally designed novel calcineurin inhibitor, exhibits a favorable safety profile, a strong correlation between pharmacokinetic and pharmacodynamic response, and a wide therapeutic window. Immunosuppressant.
Definition    ChEBI: Voclosporin is a homodetic cyclic peptide. It is a semi-synthetic calcineurin (CN) inhibitor that exhibits potent immunosuppressive activity.
Clinical Use    Voclosporin (Lupkynis(TM)) is an oral calcineurin inhibitor immunosuppressant that is being developed by Aurinia Pharmaceuticals. In January 2021, based on positive results from the pivotal phases II and III trials, oral voclosporin received its first approval in the USA for use in combination with a background immunosuppressive therapy regimen for adults with active lupus nephritis.
 

SHANGHAI MINSTAR CHEMICAL CO., LTD. is a leading, experienced, professional supplier of
API & intermediates, make-to-order, plant extract, food additive, fine chemicals and industry chemicals, etc. Our efforts are constantly dedicated to supplying customers with good quality products at competitive prices
consistent with service that meets customers’ needs. In the past years, our products were exported to more than 50 countries and regions in Asia, Europe, Africa, Middle East and America and commanded a good reputation. MINSTAR selects high technology and
market oriented products as her source of main business development strategy. Once we start, we do not just
supply our own products. And in the years of development to meet customer demand for different kinds of
products, we are helping to purchase other products too. Now we have completed our supplying chains for fine chemical & API industry, MINSTAR provides
customers with optimal solution for related products & service demand -like related production information, product knowledge, optimum application method, since we own the R&D Laboratory Department, modern
equipment, 2 production bases in Zhejiang & Anhui provinces, fundamental and specific training including
seminars